Uncovering temporospatial sensitive TBI targeting strategies via in vivo phage display.
Ontology highlight
ABSTRACT: The heterogeneous pathophysiology of traumatic brain injury (TBI) is a barrier to advancing diagnostics and therapeutics, including targeted drug delivery. We used a unique discovery pipeline to identify novel targeting motifs that recognize specific temporal phases of TBI pathology. This pipeline combined in vivo biopanning with domain antibody (dAb) phage display, next-generation sequencing analysis, and peptide synthesis. We identified targeting motifs based on the complementarity-determining region 3 structure of dAbs for acute (1 day post-injury) and subacute (7 days post-injury) post-injury time points in a preclinical TBI model (controlled cortical impact). Bioreactivity and temporal sensitivity of the targeting motifs were validated via immunohistochemistry. Immunoprecipitation-mas
SUBMITTER: Martinez BI
PROVIDER: S-EPMC9307250 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA